EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 36 / Numéro 3 (Mars 2020) Med Sci (Paris), 36 3 (2020) 264-270 Références
Open Access
Numéro
Med Sci (Paris)
Volume 36, Numéro 3, Mars 2020
Page(s) 264 - 270
Section Forum
DOI https://doi.org/10.1051/medsci/2020021
Publié en ligne 31 mars 2020
  1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 ; 126 : 663–676. [CrossRef] [PubMed] [Google Scholar]
  2. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007 ; 448 : 313–317. [Google Scholar]
  3. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 ; 131 : 861–872. [CrossRef] [PubMed] [Google Scholar]
  4. Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science 1998 ; 282 : 1145–1147. [Google Scholar]
  5. Shi Y, Inoue H, Wu JC, et al. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 2017 ; 16 : 115–130. [CrossRef] [PubMed] [Google Scholar]
  6. Karagiannis P, Takahashi K, Saito M, et al. Induced pluripotent stem cells and their use in human models of dsease and development. Physiol Rev 2019 ; 99 : 79–114. [Google Scholar]
  7. Moreno I, Míguez-Forjan JM, Simón C. Artificial gametes from stem cells. Clin Exp Reprod Med 2015 ; 42 : 33. [CrossRef] [PubMed] [Google Scholar]
  8. Hayashi K, Ohta H, Kurimoto K, et al. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 2011 ; 146 : 519–532. [CrossRef] [PubMed] [Google Scholar]
  9. Hirota T, Ohta H, Powell BE, et al. Fertile offspring from sterile sex chromosome trisomic mice. Science 2017 ; 357 : 932–935. [Google Scholar]
  10. Hayashi K, Saitou M. Generation of eggs from mouse embryonic stem cells and induced pluripotent stem cells. Nat Protoc 2013 ; 8 : 1513–1524. [CrossRef] [PubMed] [Google Scholar]
  11. Jeanisch R, Eggan K, Humpherys D, et al. Nuclear cloning, stem cells, and genomic reprogramming. Cloning Stem Cells 2002 ; 4 : 389–396. [Google Scholar]
  12. Bhartiya D, Anand S, Patel H, et al. Making gametes from alternate sources of stem cells: past, present and future. Reprod Biol Endocrinol 2017 ; 15 : 89. [PubMed] [Google Scholar]
  13. Kuiken TA, Barlow AK, Hargrove LJ, et al. Targeted muscle reinnervation for the upper and lower extremity. Techn Orthopaedics 2017 ; 32 : 109–116. [CrossRef] [Google Scholar]
  14. Gazzaniga MS. Le libre arbitre et la science du cerveau 2013 ; Paris : Odile Jacob [Google Scholar]
  15. Chneiweiss H.. Augmenter les performances du cerveau : un leurre ?. Pour la Science 2012 ; 422 : 98–105. [Google Scholar]
  16. Greene JD, Nystrom LE, Engell AD, et al. The neural bases of cognitive conflict and control in moral judgment. Neuron 2004 ; 44 : 389–400. [CrossRef] [PubMed] [Google Scholar]
  17. Phelps EA, Hofmann SG. Memory editing from science fiction to clinical practice. Nature 2019 ; 572 : 43–50. [Google Scholar]
  18. Damasio AR. Spinoza avait raison : joie et tristesse, le cerveau des émotions 2014 ; Paris : Odile Jacob [Google Scholar]
  19. Richards DJ, Coyle RC, Tan Y, et al. Inspiration from heart development: biomimetic development of functional human cardiac organoids. Biomaterials 2017 ; 142 : 112–123. [CrossRef] [PubMed] [Google Scholar]
  20. Bredenoord AL, Clevers H, Knoblich JA. Human tissues in a dish: the research and ethical implications of organoid technology. Science 2017; 355 : eaaf9414. [Google Scholar]
  21. Wu J, Greely HT, Jaenisch R, et al. Stem cells and interspecies chimaeras. Nature 2016 ; 540 : 51–59. [Google Scholar]
  22. Wu J, Belmonte JCI. Interspecies chimeric complementation for the generation of functional human tissues and organs in large animal hosts. Transgenic Res 2016 ; 25 : 375–384. [CrossRef] [PubMed] [Google Scholar]
  23. Zhong C, Wu J, Izpisua Belmonte JC. Pig chimeric model with human pluripotent stem cells. In: Hyun I, De Los Angeles A, eds. Chimera research. New York, NY : Springer New York, 2019 : 101–24. [CrossRef] [Google Scholar]
  24. Wu J, Platero-Luengo A, Sakurai M, et al. Interspecies chimerism with mammalian pluripotent stem cells. Cell 2017 ; 168 : 473–86 e15. [Google Scholar]
  25. Hashimoto H, Eto T, Yamamoto M, et al. Development of blastocyst complementation technology without contributions to gametes and the brain. Exp Anim 2019 ; 68 : 361–370. [CrossRef] [PubMed] [Google Scholar]
  26. Koplin J, Wilkinson D. Moral uncertainty and the farming of human-pig chimeras. J Med Ethics 2019 ; 45 : 440–446. [CrossRef] [PubMed] [Google Scholar]
  27. Jordan B.. Bébés CRISPR : anatomie d’une transgression. Med Sci (Paris) 2019 ; 35 : 266–270. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  28. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996 ; 86 : 367–377. [CrossRef] [PubMed] [Google Scholar]
  29. Solloch UV, Lang K, Lange V, et al. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers. Hum Immunol 2017 ; 78 : 710–717. [CrossRef] [PubMed] [Google Scholar]
  30. Joy MT, Ben Assayag E, Shabashov-Stone D, et al. CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury. Cell 2019 ; 176 : 1143–1157 e13. [Google Scholar]
  31. Xie Y, Zhan S, Ge W, et al. The potential risks of C-C chemokine receptor 5-edited babies in bone development. Bone Res 2019 ; 7 : 4. [PubMed] [Google Scholar]
  32. Mickiene˙ A, Pakalniene˙ J, Nordgren J, et al. Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population. PLoS One 2014; 9 : e106798. [CrossRef] [PubMed] [Google Scholar]
  33. Tanyel CR, Cincin ZB, Gokcen-Rohlig B, et al. Effects of genetic variants of CCR5 chemokine receptors on oral squamous cell carcinoma. Genet Mol Res 2013 ; 12 : 5714–5720. [PubMed] [Google Scholar]
  34. De Chneiweiss H.. retour de Hong Kong ou l’éthique à l’heure d’une génétique d’augmentation » de la personne humaine. Med Sci (Paris) 2019 ; 35 : 263–265. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  35. Lander ES, Baylis F, Zhang F, et al. Adopt a moratorium on heritable genome editing. Nature 2019 ; 567 : 165–168. [Google Scholar]
  36. Burt A, Crisanti A. Gene Drive: Evolved and Synthetic. ACS Chem. Biol. 2018 ; 13 : 343–346. [CrossRef] [PubMed] [Google Scholar]
  37. Rudenko L, Palmer MJ, Oye K. Considerations for the governance of gene drive organisms. Pathogens Global Health 2018 ; 112 : 162–181. [CrossRef] [Google Scholar]
  38. Macias V, Ohm J, Rasgon J. Gene drive for mosquito control: where did it come from and where are we headed?. IJERPH 2017 ; 14 : 1006. [CrossRef] [Google Scholar]
  39. Gourvest M, Brousset P, Bousquet M. Long noncoding RNAs in acute myeloid leukemia: functional characterization and clinical relevance. Cancers 2019 ; 11 : 1638. [Google Scholar]
  40. Baby V, Labroussaa F, Lartigue C, et al. Chromosomes synthétiques : réécrire le code de la vie. Med Sci (Paris) 2019 ; 35 : 753–760. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  41. Cameron DE, Bashor CJ, Collins JJ. A brief history of synthetic biology. Nat Rev Microbiol 2014 ; 12 : 381–390. [CrossRef] [PubMed] [Google Scholar]
  42. Bartley BA, Kim K, Medley JK, et al. Synthetic biology: engineering living systems from biophysical principles. Biophysical Journal 2017 ; 112 : 1050–1058. [CrossRef] [PubMed] [Google Scholar]
  43. Davies J. Using synthetic biology to explore principles of development. Development 2017 ; 144 : 1146–1158. [CrossRef] [PubMed] [Google Scholar]
  44. Jordan B. Les tests génétiques grand public en caméra cachée. Med Sci (Paris) 2011 ; 27 : 103–106. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  45. Jordan B. Synthétique, vous avez dit synthétique ?. Med Sci (Paris) 2016 ; 32 : 651–653. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.